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ABSTRACT
Carbon black is produced industrially by the partial combustion or thermal decomposition of gaseous
or liquid hydrocarbons under controlled conditions. It is considered a poorly soluble, low toxicity (PSLT)
particle. Recently, results from a number of published studies have suggested that carbon black may
be directly genotoxic, and that it may also cause reproductive toxicity. Here, we review the evidence
from these studies to determine whether carbon black is likely to act as a primary genotoxicant or
reproductive toxicant in humans. For the genotoxicity endpoint, the available evidence clearly shows
that carbon black does not directly interact with DNA. However, the study results are consistent with
the mechanism that, at high enough concentrations, carbon black causes inflammation and oxidative
stress in the lung leading to mutations, which is a secondary genotoxic mechanism. For the reproduct-
ive toxicity endpoint for carbon black, to date, there are various lung instillation studies and one short-
term inhalation study that evaluated a selected number of reproduction endpoints (e.g. gestational and
litter parameters) as well as other general endpoints (e.g. gene expression, neurofunction, DNA dam-
age); usually at one time point or using a single dose. It is possible that some of the adverse effects
observed in these studies may be the result of non-specific inflammatory effects caused by high expos-
ure doses. An oral gavage study reported no adverse reproductive or developmental effects at the
highest dose tested. The overall weight of evidence indicates that carbon black should not be consid-
ered a direct genotoxicant or reproductive toxicant.
Abbreviations: AM: alveolar macrophages; BAL(F): broncho-alveolar lavage (fluid); BAL: broncho-alveolar
lavage; CHO: Chinese Hamster Ovary; cytoB: cytochalasin B; CBPI: cytokinesis-block proliferation index;
dev: development; ELF: epithelial lining fluid; Endo III: endonuclease III; ESTR: Expanded simple tandem
repeat; FLG: few layer grapheme; Fpg: formamidopyrimidine DNA glycosylase; gd: gestational day; GL:
guideline; HPRT: hypoxanthine phosphoribosyltransferase; i.t.: intratracheal; IARC: International Agency
for Research on Cancer; LDH: lactate dehydrogenase; LOEL: Lowest Observed Effect Level; Mg/kg bw:
milligrams per kilogram body weight; Nm: nanometers; NOEL: No Observed Effect Level; OECD:
Organization for Economic Co-operation and Development; PAH: polycyclic aromatic hydrocarbons; PBS:
Phosphate buffered saline; PMN: polymorphonuclear neutrophils; PSLT: poorly soluble, low toxicity; ROS:
reactive oxygen species; SA: surface area; SCCS: Scientific Committee on Consumer Safety; SCE: sister
chromatid exchanges; TK: toxicokinetic
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Introduction
Carbon black [CAS. No. 1333-86-4] is elemental carbon in the
form of particles that are produced industrially by the partial
combustion or thermal decomposition of gaseous or liquid
hydrocarbons under controlled conditions. Commercially
available grades of carbon black differ in particle size, surface
area, average aggregate mass, morphology, or structure.
Potential health effects of carbon black have been investi-
gated extensively in laboratory animal experiments and in
epidemiological studies of carbon black production workers.
The main health concerns associated with carbon black and
other poorly soluble, low-toxicity (PSLT) particles are lung
effects resulting from inhalation exposure. The International
Agency for Research on Cancer (IARC 2010) proposed an
overall mode of action for carbon black toxicity in rat lungs.
Particle deposition above certain concentrations in the rat
lungs may lead to a phenomenon known as “lung overload”,
which in turn leads to sustained inflammation, production of
reactive oxygen species (ROS), depletion of antioxidants and/
or impairment of other defense mechanisms, cell prolifer-
ation, and gene mutations. These changes in the rat lung can
lead to the induction of alveogenic tumors. Similar tumors
have not been observed in mouse or hamster lungs.
Recently, a number of authors have indicated that carbon
black may have toxic effects that fall outside the well-under-
stood mechanism of action for PSLT particles; namely, that
carbon black may be directly genotoxic, and that it may
cause reproductive toxicity (these studies are summarized in
Tables 1–3). The purpose of this review is to critically examine
the evidence on genotoxicity and reproductive toxicity for
carbon black.
Literature search strategy
As toxicologists involved in understanding carbon black toxi-
cology and undertaking a REACH registration of carbon black,
we have been compiling data on carbon black health effects
over a period of at least 20 years. Journal articles related to
carbon black toxicology were identified from comprehensive
literature searches primarily in the United States National
Library of Medicine PubMed and TOXNET databases, supple-
mented by the evaluation of the reference lists of reviews
and key publications. For this paper, any studies published by
April 2017 related to genotoxicity, mutagenicity, reproductive
toxicity, or developmental toxicity of carbon black were iden-
tified and reviewed. This paper is a targeted comprehensive
review of these endpoints, therefore published in vitro and in
vivo studies related to these endpoints were included for
review regardless of quality or limitations of study design.
Carbon black composition, uses, and exposure potential
The physical appearance of carbon black is that of a black,
finely divided powder, consisting of aggregates (in the size
range between 100 and 1000 nm) of aciniform morphology
(i.e. aggregates that have been strongly fused together in
random configuration that resemble grape-like clusters) (Gray
and Muranko 2006). Primary particles, which are defined
according to ISO as “the original source particles of agglom-
erates or aggregates or mixtures of the two” are not discern-
ible anymore after completion of the manufacturing process.
The aciniform aggregates constitute the smallest inseparable
entities in manufactured carbon black and are hence the fun-
damental structural units of carbon black. However, even the
carbon black aggregates are not readily available outside the
closed reaction chamber of the manufacturing process as,
within the reaction chamber, the aggregates rapidly form
larger agglomerates held together by van der Waals forces.
Carbon black agglomerates often are compressed into even
larger-sized pellets as a final step in the manufacturing
process.
Carbon black is sometimes used in toxicology studies to
represent environmental carbonaceous particles in air pollu-
tion studies (Reisetter et al. 2011). However, it is important
not to confuse carbon black with “soot” or “black carbon”
which are names applied to carbonaceous emissions from
fires and incomplete combustion of carbon-containing fuels
and products (e.g. waste oil, fuel oil, gasoline fuel, diesel fuel,
coal, coal-tar pitch, oil shale, wood, paper, rubber, plastics
and resins, household refuse, etc.). Such emissions are not
only comprised of some elemental carbon but also of signifi-
cant quantities of organics and other compounds (Watson
and Valberg 2001). For example, combustion soot is a highly
heterogeneous substance that generally includes a major
organic carbon fraction (often >50% of total mass) and sig-
nificantly higher ash and extractable organic matter contents
than carbon black. The chemical and physical properties of
combustion soot are highly variable depending on its source
(Long et al. 2013). In contrast, commercially produced carbon
black is composed of mainly carbon with only traces of other
substances (McCunney et al. 2012).
Carbon black has been commercially produced worldwide
for more than 100 years. Worldwide production in 2012 was
about 24 billion pounds [11 million metric tons] (ICBA 2016).
About 89% of total manufactured carbon black consumption
is in the rubber industry. Of that, 70% goes toward automo-
tive and truck tires, and related tire products; and, approxi-
mately 10% is in other automotive rubber products, such
as belts, hoses, and related accessories. The final 9% is
consumed in rubber products unrelated to the automotive
industry. The remaining 11% of total production is used in
non-rubber applications such as paints, inks, coatings, plas-
tics, electrostatic discharge compounds, ultraviolet light
absorption applications, and as a chemical reagent (Wang
et al. 2004).
Occupational exposure to carbon black may arise during
the manufacture of carbon black and during its use in the
formulation of rubber, printing ink, paints as well as other
uses. The results of large-scale multiphase industry-wide
exposure assessment surveys in Europe and the USA have
shown that by the mid- to late-1990s the geometric mean
levels of inhalable dust in manufacturing facilities were below
2mg/m3 [discussed in IARC (IARC 2010)]. In nearly all cases of
use, carbon black is incorporated into a rubber or polymer
matrix, in which carbon black is tightly bound within other
materials. A study of carbon black in food contact plastics
showed that carbon black particles do not migrate out of
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plastic materials once incorporated (Bott et al. 2014). Indeed,
IARC recognized and noted the unique nature of carbon
black and the distinction between pure and bound-in-matrix
carbon black: “End-users of these products (rubber, ink or
paint) are not exposed to carbon black per se, since it is
bound within the product matrix” (IARC 2010).
Mechanism of toxicity of carbon black
Long-term inhalation exposure of rats to carbon black leads
to the development of lung tumors (Mauderly et al. 1994;
Heinrich et al. 1995; Nikula et al. 1995). The mechanism of
tumor induction in rats by carbon black is considered to be
representative of and common to PSLT particles, such as
titanium dioxide (Mauderly 1997; Nikula 2000). Studies with
carbon black and other PSLT particles indicate that the lung
tumors in rats are a generic response to lung overload and
subsequent chronic inflammation. At high particle concentra-
tions, the ability of the rat lung to remove particles becomes
impaired. A persistent particle burden in rat lungs leads to
pulmonary inflammation, which causes DNA damage, epithe-
lial cell proliferation, and fibrotic changes (Mauderly and
McCunney 1996; Nikula 2000).
The adequacy of the rat as a reliable model for predicting
human lung cancer risk of PSLT particles is a matter of con-
troversy in the scientific community and continues to be
questioned (ILSI 2000; ECETOC 2013; Morfeld et al. 2015;
Warheit et al. 2016). Compared to other species, it appears
that rats exhibit an exaggerated response to high concentra-
tions of inhaled, insoluble particles. In contrast to rats, mice
do not develop lung tumors after long-term exposure to car-
bon black or other PSLT (Heinrich et al. 1995). Lung overload
effects after exposure to carbon black have also not been
observed in hamsters (Elder et al. 2005). Moreover, epidemio-
logical evidence from carbon black production workers
chronically exposed to carbon black has not shown consistent
patterns of either an elevated risk of lung cancer or a dose–r-
esponse trend [discussed in IARC (2010) and Dell et al.
(2015)]. Also, no association of carbon black exposure with
inflammation markers (number of white blood cells, neutro-
phils, lymphocytes, T cells, CD4þ, CD8þ, B cells, NK cells, and
monocytes) in blood of exposed workers was found in a
recent epidemiological study (0.66mg/m3 elemental carbon,
measured in personal samples from 8 packing workers); a
borderline, possibly allergy-induced, increase in eosinophil
count, was only significant in workers that have never
smoked (Dai et al. 2016). At an excessive workplace concen-
tration of 14.90mg/m3 (measured by personal air samplers),
however, increases in IL-1b, IL-6, IL-8, MIP-1beta, and TNF-
alpha were found (Zhang et al. 2014).
Absorption, distribution, and excretion of carbon black
In order to understand the potential for carbon black to
cause primary genotoxicity or reproductive toxicity, it is
important to consider the toxicokinetic (TK) behavior of car-
bon black in the body. Inhalation exposure is the most rele-
vant route for particles, as inhalation represents the mainTa
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route of exposure in the occupational setting. However, an
inhalation absorption or TK study evaluating distribution to
other parts of the body has not been identified for carbon
black. In a study evaluating the kinetics of carbon black fol-
lowing oral administration, weanling (4weeks old) and aged
(18months old) female Swiss mice received a single dose of
7mg 7Be-labelled carbon black particles (27 nm diameter) by
gavage. Isotope distribution was measured at 4 h and 1, 2, 5,
and 14 days after administration. Radioactivity in extra-intes-
tinal viscera and blood was extremely low and practically all
the label was excreted in the feces; most of it during the first
day. At 4 h post-dosing, the total radioactivity in the body
(excluding intestines) was approximately 0.01% of the dose in
weanlings and 0.005% of the dose in adults. Less than
0.001% of the radioactive dose was also found in the urine at
1, 2, and 5 days post-dosing. The level of radioactivity in the
intestines (tissues only) was 0.006% or 0.028% of the dose in
weanlings and adults, respectively. About 30 and 20% of this
radioactivity were associated with Peyer’s patches in wean-
lings and in aged mice, respectively. This presence was con-
firmed histologically by the presence of carbon black
particles within Peyer’s patch macrophages (LeFevre and Joel
1986). These results indicate that carbon black is essentially
non-absorbed following oral administration.
Graphenes are a form of insoluble carbonaceous material
that have certain physical/chemical characteristics that are
similar to carbon black. A pulmonary biodistribution study of
few layer graphenes (FLG) is available, where FLGs intratra-
cheally instilled into mice showed that greater than 93% of
the instilled dose was retained in the lung or excreted
through the feces (the dose in the lung was estimated to be
5mg) (Mao et al. 2016). The FLG used in this study had hydro-
dynamic diameters between 100 and 1000 nm. The insolubil-
ity and chemical makeup of graphenes suggest that the
absorption, distribution, and excretion characteristics of gra-
phenes and carbon black are likely to be similar. In this study,
14C-labeled FLG was utilized to quantify the in vivo distribu-
tion and excretion in mice up to 28 and 3 days after intratra-
cheal instillation or oral gavage, respectively. Intratracheally
instilled FLG was mainly retained in the lung with 47%
remaining after 4weeks. About 46.2% of the intratracheally
instilled FLG was excreted through the feces 28 days after
exposure. The results showed that intratracheally instilled FLG
was mainly retained in the lung or excreted, and there was
minimal distribution into other tissues.
Therefore, based on TK studies on carbon black and similar
materials, and its known physico-chemical properties, indus-
trially produced carbon black is unlikely to be absorbed to
any meaningful extent or distributed in the body.
Evaluating the evidence for genotoxicity
An extensive database of in vitro and in vivo mutagenicity
and genotoxicity studies exists for carbon black, comprising
studies performed with standard protocols, non-standard pro-
tocols, or novel approaches. An overview of the available
data can be found in Table 1 (in vitro data) and Table 2
(in vivo data). In general, in vivo tests are given more weight
in determining whether a substance should be considered a
mutagen. In this review, both in vitro and in vivo tests of
mutagenicity are evaluated to determine the weight of
evidence.
Summary of in vitro data
Mutagenicity – bacterial cell systems. Carbon black has been
tested in vitro for gene mutations in bacteria (Ames tests)
and mammalian cells [mouse lymphoma tests, hypoxanthine
phosphoribosyltransferase (HPRT) tests], for aneugenic and
clastogenic effects (several micronucleus tests), and for sister
chromatid exchanges. In the majority of the published stud-
ies, however, only indicator tests were used, such as the alka-
line comet assay. No evidence for mutagenicity was found in
Ames tests performed according to the current Organization
for Economic Co-operation and Development (OECD) testing
guideline 471. The majority of tests performed with carbon
black extracts (Soxhlet extraction with toluene for several
hours) were negative. Some positive results were found with
Soxhlet extracts of pre-1979 produced carbon blacks (N330,
Black Pearls L) probably due to nitropyrene impurities, dem-
onstrating the mutagenic potential of impurities in carbon
black (Rosenkranz et al. 1980). However, more recent studies
in biofluids have shown that polycyclic aromatic hydrocar-
bons (PAHs) from N330 are not bioavailable (Borm et al.
2005).
Mutagenicity – mammalian cell systems. Small increases in
mutation frequency at cll and lacZ loci (1.4- and 1.2-fold,
respectively) were reported in the FE1MML MutaMouseTM
epithelial cell line after excessive exposure causing cytotox-
icity (576 h, total 6mg carbon black) (Jacobsen et al. 2007,
2011).
Mouse lymphoma cells were exposed for 3 h to carbon
black particles both in the presence and absence of meta-
bolic activation. No mutagenic activity was found (Lloyd
2011). As the EU Scientific Committee on Consumer Safety
(SCCS 2015) speculate, the exposure might have been too
short for cellular uptake of the particles (which has not been
investigated). However, as separation of the insoluble carbon
black particles from the cells after exposure is difficult, if not
impossible, sufficient exposure of cells is likely [see also
Kirwin et al. (1981)].
Clastogenicity. The chromosome-damaging potential of car-
bon black was explored in vitro using the micronucleus test
which detects both potential aneugens and clastogens. In
this assay, cytochalasin B (cytoB) is often used to block cyto-
kinesis, resulting in binucleate cells and allowing for the iden-
tification and analysis of micronuclei in only those cells that
have undergone a complete mitosis. CytoB also inhibits endo-
cytosis, and thus might reduce or prevent cellular uptake of
particles (Gonzalez et al. 2011).
No evidence for chromosomal damage was found in a com-
prehensive in vitro micronucleus study using mouse RAW
264.7 macrophages exposed to carbon black (Printex 90) con-
centrations of up to 100mg/L for 48 h; a delayed co-treatment
with 4mg/L cytoB was used (Migliore et al. 2010). Another
micronucleus test in RAW 264.7 macrophages was negative at
1mg/L, but slightly increased (less than 2-fold) micronuclei fre-
quencies were found at test concentrations of 3 and 10mg/L;
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there were acentric chromosome fragments present at all
concentrations tested. However, due to insufficient historical
control data, the relevance of the chromosomal effects
was considered uncertain (Di Giorgio et al. 2011).
A dose-dependent increase in the frequency of micronuclei
was also reported in an earlier study with the RAW 264.7
cell line after 48 h of incubation at comparatively low doses
(1, 3, and 10 mg/cm2, corresponding to 2.2, 6.6, and
22mg/L) (Poma et al. 2006). No clastogenic and no aneu-
genic activity was found in a test using Chinese Hamster
Ovary (CHO) cells up to the highest tested concentration of
120mg/L; however, the incubation time was only 3 h
(Lloyd 2012).
An increase in the frequency of micronuclei was found in
the human lung carcinoma cell line A549 when exposed to
Printex 90 for 6 h; the response showed a plateau at 2mg/L,
with no further increase at higher concentrations. Cell growth
was reduced by 60% at the highest dose tested (200mg/L). In
this study, no cyto B was used; however, solvent control cul-
tures (0.9% saline with 0.05% v/v Tween 80, serum) also
showed an increase in micronucleus frequency after 48 h. No
further data were reported on the solvent controls nor on
cytotoxicity (Totsuka et al. 2009). When treated for 48 h, with
cytoB added 18 h before harvesting, a less than 2-fold increase
in micronuclei and cytoskeleton disruption was found in an
undifferentiated embryonic hamster epithelial cell line at
“almost negligible cytotoxicity” (Riebe-Imre et al. 1994).
Carbon black did not induce sister chromatid exchanges
(SCE) in CHO cells (Kirwin et al. 1981). Cell transformations
were not found in a validated mouse fibroblast model (Kirwin
et al. 1981), while the results reported in a non-validated and
undifferentiated embryonic hamster epithelial cell line (Riebe-
Imre et al. 1994) are considered inconclusive.
Overall, the standard in vitro genotoxicity studies in mouse
lymphoma and CHO cells were all negative. The results of
micronucleus studies in macrophages and A 549 cells were
however inconclusive.
PAH-DNA adducts. Industrially manufactured carbon black
is produced by pyrolysis of hydrocarbons at high tempera-
tures under controlled process conditions. This process results
in the formation of unavoidable trace levels of organic impur-
ities, such as PAHs. In a study to test the possible release of
PAHs from commercial carbon black and their ability to form
PAH adducts, PAH adducts were analyzed in lung epithelial
cells (A549) after exposure to either original carbon black par-
ticles (Lampblack 101, Sterling V, N330, and Printex 90), tolu-
ene Soxhlet-extracted particles or to the toluene extracts
transferred into DMSO. The cells were incubated with original
and extracted carbon black particles in concentrations
between 30 and 300 lg/cm2. Adduct spots were found with
Sterling V only. However, there was no dose–response rela-
tionship and the spot remained unidentified (Borm et al.
2005).
Indicator tests, including comet assays. Indicator tests detect
DNA damage or specific mutations (Nikolova et al. 2014),
which are the first in a line of events that may lead to per-
manent change. The comet assay is used to detect strand
breaks induced in cellular DNA and involves electrophoresis
at high pH. Strand breaks results in structures resembling
comets, where the intensity of the comet tail relative to the
head reflects the number of DNA breaks.
Due to the current lack of an agreed in vitro comet OECD
testing guideline, different methods have been used to test
carbon black. Therefore, it is difficult to derive any firm con-
clusions from the many reported tests on carbon black
using the comet assay (Table 1). However, the data show
that DNA damage was in most cases associated with cyto-
toxicity, and that there is evidence of oxidative DNA dam-
age (as shown in the formamidopyrimidine DNA glycosylase
(Fpg)-modified comet assay; a modification that detects oxi-
dized purines). Clearly cytotoxic doses induced oxidative
damage in the FE1-MML MutaMouseTM epithelial line
(Jacobsen et al. 2007), single-strand breaks in human A549
cells (Mroz et al. 2007, 2008), and oxidative DNA damage in
mouse embryo fibroblasts (Yang et al. 2009) and in HUVEC
cells (Frikke-Schmidt et al. 2011). DNA damage at low or
non-cytotoxic doses was noted in RAW 264.7 mouse macro-
phages after 24 h exposure (Di Giorgio et al. 2011; Rim
et al. 2011), and in human A549 and monocytic T-cells
(THP-1) after 48 h exposure (Don Porto Carero et al. 2001),
while in another study no DNA damage was reported in
A549 cells exposed to up to 40 mg/cm2 for only 4 h
(Karlsson et al. 2008). Oxidative damage was also found in
HepG2 cells at a concentration of 25mg Printex 90/L
(Vesterdal et al. 2014). A dose of 20 mg Printex 90/cm2 for
4 h did not induce DNA damage in human Caco-2 intestinal
carcinoma cells (Gerloff et al. 2009), and up to 138 mg car-
bon black/cm2 was negative in human embryonic lung cells
and Chinese hamster V79 cells (Zhong et al. 1997).
Of note is that, after Printex 90 exposure, DNA single-
strand breakage in human alveolar epithelial type II (A549)
cells was significantly mitigated by the addition of epithelial
lining fluid (ELF), suggesting that ELF plays a protective role
against particle induced oxidative stress and DNA damage
(Chuang et al. 2013).
Summary of in vivo data
In vivo studies with carbon black include tests for germ cell
mutations, mutations in the hprt gene, mutations in the p-53
gene, DNA adducts, and indicator tests for DNA damage and
repair. An overview of the available studies is presented in
Table 2.
Germ cell mutations. The effects of Printex 90 on female
germ cell mutagenesis were studied in pregnant mice intra-
tracheally instilled four times with 67 mg per animal, given
during the critical developmental stages of fetal oogenesis
(gestation days 7, 10, 15, and 18) (Boisen et al. 2013). The
dose induced persistent pulmonary inflammation in the ani-
mals. Female offspring were raised to maturity and mated
with unexposed males. Expanded simple tandem repeat
(ESTR) germline mutation rates in the resulting F2 generation
were determined from full pedigrees (mother, father, and off-
spring) of F1 female mice. ESTR mutation rates in carbon
black-exposed F2 female offspring were not statistically differ-
ent from those of F2 female control offspring. The observed
mutation rate in germ cells of carbon black-exposed F1
females was not significantly different from that of controls.
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Although the study protocol has not been internationally vali-
dated, the sensitivity of the model and the high dose
employed gives reasonable confidence that carbon black
would not induce mutations in oocytes.
Somatic cell mutations. A significant and dose-related
increase in the hprt mutation frequency in rat alveolar epithe-
lial cells was detected immediately after 13weeks of inhal-
ation exposure to 7.1 and 52.8mg/m3 carbon black (Monarch
880, 220 m2/g) as well as after 3- and 8-month recovery peri-
ods for the groups exposed to 52.8mg/m3. No effect was
found in the epithelial cells of rats exposed to 1.1mg/m3
[which was the no observed adverse effect level (NOAEL)].
Exposure to 52.8mg/m3 carbon black resulted in hprt muta-
tion frequencies which were 4.3-, 3.2-, and 2.7-fold greater
than the air control group, immediately and after 3 and
8months post-exposure, respectively. A significant increase in
the frequency of hprt mutations was detected after 13weeks
of exposure to 7.1mg/m3 carbon black but not after 3 or
8months of recovery. Lung tissue injury and inflammation,
increased chemokine expression, epithelial hyperplasia, and
pulmonary fibrosis were observed after exposure to 7.1 and
52.8mg/m3, with these effects being more pronounced at
the higher exposure level (Driscoll et al. 1996).
In a subsequent study (Driscoll et al. 1997), the relation-
ship between the severity of inflammation and mutations
was confirmed by co-incubating lung lavage inflammatory
cells from carbon black exposed rats with lung epithelial cells
from unexposed rats. Bronchoalveolar lavage (BAL) cells were
isolated from the lung of rats 15months after intratracheal
instillation of saline or saline suspensions of carbon black
(Monarch 900, 230 m2/g) at 10 and 100mg/kg bw. When the
percentage of neutrophils in the lavage fluid was50%, the
hprt mutation rate increased significantly, possibly related to
the generation and release of reactive oxygen species (ROS)
and/or depletion in antioxidants. The mutation spectrum was
compatible with mutations being caused by ROS.
Importantly, mutations in the hprt gene occurred only at the
high-dose exposure concomitantly with inflammation and
epithelial hyperplasia.
In a study comparing inflammatory responses and ex vivo
hprt mutation frequencies in rats, mice, and hamsters after
subchronic inhalation exposure to carbon black (1, 7, or
50mg/m3), rats demonstrated greater propensity for generat-
ing a pro-inflammatory response and hprt mutations at the
higher doses of 7 and 50mg/m3. No effects on hprt mutation
frequencies were found at a dose level of 1mg/m3, which
was also a dose at which inflammatory effects were not
observed. These results show that chronic inflammation at
higher exposures may lead to a secondary indirect genotoxic
response (Carter et al. 2006).
Some rat lung tumors from a carcinogenicity study with
carbon black (Nikula et al. 1995) were analyzed for mutations
in the K-ras or p53 genes. Only very low levels of either K-ras
or p53 genes were mutated; there were no significant differ-
ences between the yields of mutants recovered from diesel
exhaust, carbon black or sham-exposed rats (Swafford et al.
1995; Belinsky et al. 1997). The lung tumors analyzed for the
K-ras gene mutation all came from a single carbon black-
exposed rat. These small sample sizes limit the reliable
interpretation of the reported results. It is further noted that
in rat lungs – unlike the situation in human and mice lungs –
the induction of p53 and/or K-ras mutations is generally very
low (Rosenkranz 1996). In the same tumor samples, hyperme-
thylation (inactivation) of the p16 gene (a gene involved in
the inhibition of cell-cycle progression) further supports a
role for oxidative stress and inflammation in the etiology of
these tumors (Belinsky et al. 2002).
In the gpt delta transgenic mouse model, in which point
mutations and deletions can be analyzed separately by two
distinct selection methods (gpt and Spi assays), no increases
in mutant frequencies were found in the lungs after intratra-
cheal instillation of 0.2mg Printex 90 per animal (Totsuka
et al. 2009).
DNA adducts. Carbon black did not induce DNA adduct
formation in the lungs or livers of rats (Wolff et al. 1990;
Gallagher et al. 1994; Borm et al. 2005; Danielsen et al. 2010).
Borm et al. (2005) analyzed DNA obtained from lung homo-
genates isolated immediately after 13weeks of inhalation
exposure to up to 50mg/m3 of Printex 90 and Sterling V
resulting in lung burdens of 4.9 and 7.6mg, respectively.
32P-post-labeling of lung DNA showed no spots relating to
PAH-DNA adduct formation when compared to sham-
exposed animals. An increase of adducts in rat alveolar type
II cells when compared to the filtered-air controls was
reported (Bond et al. 1990), however, the same low-surface
area carbon black tested negative in another study (Wolff
et al. 1990). The overall interpretation by IARC of these inves-
tigations was that carbon black does not cause DNA adduct
formation (IARC 2010).
DNA damage and DNA repair. DNA damage and repair was
studied in rats in two subchronic studies investigating oxida-
tive damage in lung tissue. One study used intratracheal
instillation (Ziemann et al. 2011; Rittinghausen et al. 2013), in
the other, inhalation exposure was used (Gallagher et al.
2003). At a clearly inflammatory dose (3 6mg/rat by intra-
tracheal instillation, once a month for 3 months),
Rittinghausen and coworkers found increased levels of certain
genotoxic stress markers in pulmonary alveolar lining cells.
The authors describe the results as “in line with ongoing ROS
production and oxidative DNA damage/repair during inflam-
matory processes” (Rittinghausen et al. 2013).
A No Observed Effect Level (NOEL) of 1mg/m3 could be
derived from a 90-day inhalation study, with the Lowest
Observed Effect Level (LOEL) for oxidative damage (8-oxo-dG
in lung DNA) at 7mg/m3 for high-surface area carbon black
(Printex 90, 300 m2/g), and at 50mg/m3 for low surface
area carbon black (Sterling V, 50 m2/g) (Gallagher et al. 2003).
An increase in 8-oxo-dG formation was observed at 50mg/m3
Printex 90, after 13weeks of exposure and after 44weeks of
recovery and at 7mg/m3 only after 44weeks of recovery. No
increase in 8-oxo-dG was observed at 1mg/m3 or for any
exposures of Sterling V.
In a comparative study in rats, using single intratracheal or
intragastric administrations of 0.64mg/kg (corresponding to
ca. 128 mg) of Printex 90, no oxidative damage was reported
in the lungs or liver after intratracheal administration; how-
ever, increases in 8-oxo-dG (23%) and etheno-adduct levels
(54–75%) were reported in the liver after intragastric (gavage)
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administration (Danielsen et al. 2010). The intratracheal dose
employed was considered by the authors to be “probably
below the overload threshold” as inflammatory markers in
broncho-alveolar lavage (BAL) were not increased at 24 h
after instillation. mRNA levels of genes related to oxidative
stress were increased only after intragastric administration.
The elevated etheno-adduct levels might have been second-
ary to macrophage activation and oxidative stress following
the bolus (gavage) administration of the particle suspension.
Endotoxins contained in the administered formulations could
also have further stimulated macrophage activation.
Comet assays. Several studies with carbon black have used
the comet assay to investigate effects on DNA.
Inhalation studies (rat, mouse). In rats exposed to 6mg/m3
Printex 90 by nose-only inhalation for 14 days (6 h/day,
5 days/week), no DNA strand breaks or oxidative DNA dam-
age was found in BAL cells with the comet assay, measured
at day 1 and day 14 post-exposure (Lindner et al. 2017). Also
in mice, no DNA damage was found in BAL cells of dams and
their offspring after inhalation exposure (whole-body) of the
pregnant mice to 42mg/m3 (1 h/day, gd8–18); however, an
increase in DNA lesions/106 base pairs was found in livers of
both dams and offspring. The level of oxidatively generated
DNA damage in the liver was not increased [only determined
in the offspring by the level of formamidopyrimidine DNA
glycosylase (fpg) enzyme sensitive sites]. Analysis of BAL fluid
cell composition demonstrated the presence of inflammation
in the lungs. The observed effects in the liver of dams were
most likely due to fur grooming and therefore due to gastro-
intestinal particle exposure, whereas the effect in the off-
spring could have been mediated by maternally induced
inflammatory cytokines (Jackson et al. 2012a). The observed
effects could however also have been within the normal
physiological variation (historical controls were not reported).
Increased DNA strand breaks in BAL were found 1 h after
inhalation exposure of TNF-deficient mice to 4 20mg/m3
(for 1.5 h each); less damage was found in TNFþ/þmice,
which might be explained by the fact that TNF induces neu-
trophil apoptosis as a mechanism for removal of neutrophils
(Murray et al. 1997; Saber et al. 2005).
Intratracheal instillation studies (mouse). Comet effects were
found in BAL fluid of mice at day 1 and day 28 after single
instillation of 18 mg Printex 90/mouse (vehicle: physiological
saline containing 10% BAL from untreated mice of the same
strain), after 28 days when 54 mg were applied, and after 1, 3,
and 28 days when 162mg were instilled. In hyperlipidemic
Apo/ mice, which are particularly sensitive, the comet assay
was positive at 3 h after instillation of 54 mg. It was reported
that the vehicle used in these studies contained parti-
cles>20 nm (Jacobsen et al. 2009; Bourdon et al. 2012b,
2012c); no increase was found at day 1 post-exposure in
mice dosed with 54 mg/animal, using the same vehicle (Saber
et al. 2012). Comet effects were also found at 3 h and 3days
after a single instillation of 162 mg/mouse, but not anymore
after 43 days. In this study, a suspension in nanopure water
was used (Husain et al. 2015), which results in smaller particle
sizes than the suspension in saline plus BAL. Increases in
%tail DNA (the recommended parameter by the OECD test
guideline on the in vivo comet assay) were found in a recent
study only at the first measured time-point (1 day) after a sin-
gle instillation of low doses (0.67 and 2mg/animal, as suspen-
sions in nanopure water with hydrodynamic particle
diameters of ca. 800 and 900 nm, respectively), whereas no
increase was noted at 6 and 162 mg/animal (hydrodynamic
diameters around 100 and below 100 nm, respectively). When
measured as tail length, DNA damage increased on day 3 in
the 2 and 6 mg groups, and on day 28 in the 0.67 and 2 mg
groups. A persistent inflammatory response was only seen in
the high-dose group (162 mg/animal), but a significant
increase in BAL neutrophil count was found at all dose levels
on day 1 post-exposure (Kyjovska et al. 2015). In none of the
low-dose groups was the percentage of neutrophils in BALF
close to the numbers associated with an increased mutation
frequency as shown in the study by Carter et al. (2006). It has
been reported that smaller particles may be cleared less effi-
ciently than larger sized particles due to impaired phagocyt-
osis (IARC 2010). The time course and magnitude of the
observed effects in the low dose range might therefore be
explained with the size-dependent efficiency with which mac-
rophages eliminate particles after having been triggered by
neutrophil recruitment (Bellingan and Laurent 2008; Hirota
and Terada 2012). In phagocytic cells, autophagy and apop-
totic pathways have been described for carbon black
(Hussain et al. 2010; Stern et al. 2012; Kong et al. 2017),
which may lead to typical comet effects (Choucroun et al.
2001) and could explain the observations in the study by
Kyjovska et al. (2015). Importantly, faster clearance would
hence not result in fewer comet-like structures. In contrast,
these structures are likely originating from the phagocytic
activity of neutrophils in the first phase after exposure, fol-
lowed by a second phase dominated by macrophage activity.
Because the phagocytic uptake of apoptotic cells is anti-
inflammatory (Aderem and Underhill 1999; Aderem 2003;
Arandjelovic and Ravichandran 2015) and not associated with
significant ROS production unless overload conditions occur,
the low-dose findings in the study by Kyjovska et al. (2015)
should not be considered as adverse.
In lungs, DNA strand breaks were found after instillation of
18, 54, and 162 mg Printex 90/mouse (in physiological saline
containing 10% v/v acellular BAL from C57BL/6 mice). At 54
and 162 mg, the effects were still present at day 28 post-instil-
lation, but fpg-sensitive sites were only found at day 1 (in all
dose groups) and at day 3 in the 162 mg group, but no longer
on day 28 (Bourdon et al. 2012b). DNA strand breaks were
also found at 3 and 24 h after a dose of 200 mg/animal; 50 mg/
animal were however without effect (Totsuka et al. 2009). No
effects on %tail DNA were found in lung tissue after a single
dose of 0.67 mg/mouse, but 28 days post-exposure to 2mg,
and at day 1 after 162 mg (Kyjovska et al. 2015), an effect that
is most likely associated with macrophage recruitment from
BAL into the lungs (as shown by macrophage counts in BALF
reported in the paper) and subsequent phagocytic activity.
A dose of 6 mg caused a small increase in tail length only.
The apparent lack of a dose–response is well explained by (a)
the higher efficiency with which macrophages can phagocyt-
ize the bigger aggregates in the 2 mg group as compared to
the other groups and (b) the overload situation in the 162 mg
group which causes a massive macrophage recruitment into
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the lungs. No information on oxidative DNA damage was pro-
vided in the paper.
In livers, no DNA strand breaks were found at 1, 3, and
28 days after a single instillation of 0.67, 2, 6, or 162mg
Printex 90/animal (Kyjovska et al. 2015). DNA strand breaks
were reported 24 h and 28 days after single intratracheal
doses of 18, 54, or 162 mg/animal (Bourdon et al. 2012b) and
also in livers of offspring whose mothers were intratracheally
treated during pregnancy with 4 67 mg/dam (Jackson et al.
2012a). The DNA strand breaks in liver were considered not
to be caused by a direct interaction with carbon black
particles (Jackson et al. 2012a; Kyjovska et al. 2015).
Artifacts and “irrelevant positives”
Carbon black, mainly due to its insolubility, adsorption cap-
acity, and optical properties poses particular challenges to
toxicological testing and the results are prone to artifacts
(Monteiro-Riviere and Inman 2006; Kroll et al. 2009; Kroll
et al. 2012). In particular, in vitro tests in which cytotoxicity
and/or cell viability are measured are readily disturbed by
interferences in colorimetric assays. Dispersions of carbon
black have been shown to interfere with optical detection
systems in several assays, including lactate dehydrogenase
(LDH) and ROS measurements and can create both false
negative as well as irrelevant positive results (Kuhlbusch et al.
2009; Almutary and Sanderson 2016). Moreover, settling and
adsorption of the test substance to the test tubes and plates,
and to nutrients, proteins and vehicle constituents during
test substance preparation and administration as well as to
cells during the incubation step of in vitro assays may influ-
ence (diminish or enhance) the effect(s) under investigation
(Kroll et al. 2011). In only a few of the reported in vitro stud-
ies is an assessment made of particle interference with the
endpoint being measured, e.g. by Cao et al. (2014). Positive
in vitro findings in cells directly exposed to extreme doses of
carbon black in test systems for which it is known that car-
bon black interferes with assay components should therefore
not be considered as an indication of primary genotoxicity.
Indicator tests are useful tools for preliminary screening
and for mechanistic studies, e.g. for the detection of oxidative
DNA damage. However, they are not suitable to differentiate
between primary or secondary genotoxicity mechanisms. For
example, in the in vitro comet assay, particles remain in close
proximity to the virtually naked DNA following the lysis of
agarose-embedded cells with the consequence that they may
interact with DNA and create artifactual findings. Such a scen-
ario is not expected to occur in intact cells or in vivo where
the barrier of the nucleus protects the DNA molecule
(Rittinghausen et al. 2013). According to the most recent
OECD guidance document on genotoxicity testing (OECD
2015) “When evaluating potential genotoxicants, more weight
should be given to the measurement of permanent DNA
changes than to DNA damage events that are reversible. In
general, indicator tests should not be used in isolation and a
substance should not be considered mutagenic (or non-muta-
genic) on the results of indicator tests alone”.
Also, the comet studies in mice with single or multiple
intratracheal instillations may be considered useful as
preliminary screens to explore a potential hazard. However,
because local bolus doses are applied, the physiological
defense and internal repair mechanisms are usually over-
whelmed and this may induce abnormal or artifactual
responses. Jacobsen et al. (2009) report that at similar lung
doses, the inhalation of carbon black causes much less
inflammation than instillation. In a study in hyperlipidemic
ApoE/ mice, the neutrophils in BALF – a marker for pul-
monary inflammation – reached 76% following instillation of
54 mg/animal, whereas only 6% were found following a single
inhalation exposure to 60mg/m3 for 90min. High neutrophil
counts in BAL are linked to increased ROS production and a
secondary genotoxic mechanism.
Furthermore, it is currently not possible with the in vivo
comet assay to differentiate between different cell types
within the investigated organ or tissue (e.g. between macro-
phages and epithelial cells). This assay is therefore of limited
use to differentiate between primary and secondary
genotoxicity.
Weight-of-evidence for a primary genotoxicity of carbon
black
Primary genotoxicity by particles has been defined as
“genetic damage elicited by particles in the absence of pul-
monary inflammation”. It is characterized by a direct physical
interaction or an oxidative attack by ROS at the particle sur-
face on the genomic DNA or its associated components
(Schins and Knaapen 2007; DFG 2013). For carbon black,
however, a secondary genotoxic mechanism has generally
been demonstrated and accepted, as genotoxicity is only
observed at concentrations that also cause persistent inflam-
mation. The available experimental in vitro data as well as the
ex vivo and in vivo data in rats support such a secondary
mechanism for genotoxicity (IARC 2010).
Recently, however, it has been postulated that carbon
black also has a primary (direct or indirect) genotoxic effect
on DNA (Jacobsen et al. 2007, 2008; Botta and Benameur
2011; Ziemann et al. 2011; Kyjovska et al. 2015; SCCS 2015).
However, our weight-of-evidence analysis of all the available
genotoxicity data indicates a secondary or indirect genotoxic
mechanism for carbon black. Details on the available geno-
toxicity tests are summarized in Tables 1 and 2 for in vitro
and in vivo studies, respectively.
Carbon black did not induce DNA-adduct formation in the
lungs of rats (Wolff et al. 1990; Gallagher et al. 1994; Borm
et al. 2005). The lack of DNA-adduct formation strongly sup-
ports the view that no direct interaction occurs between
carbon black and DNA.
All in vitro guideline tests in mammalian cell systems
(Mouse Lymphoma and CHO cells) were negative for gene
mutations and chromosomal aberrations (summarized in
Table 1). A limitation is that carbon black uptake into the
cells was not measured, and in some studies, the duration of
exposure may be considered too short. It is however difficult
to completely wash-off adsorbed carbon black particles from
cell surfaces, therefore the exposure duration may in fact be
longer than assumed. These studies do not provide evidence
for primary genotoxicity. The results of the in vitro
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micronucleus tests were inconclusive and may have been
influenced by different testing conditions. Positive results
were found at subtoxic levels in studies using immune cells
(mainly mouse peritoneal macrophages); the chromosomal
damage therefore was likely caused by phagocytosis.
Recently reported DNA strand breaks in BALF and lung cells
of mice after single intratracheal bolus doses were not associ-
ated with persistent inflammation and therefore assumed to
be indicative of a primary genotoxic mode of action by the
study authors. Given the differential cell count in BALF and
the time course and magnitude of DNA effects, it is however
more likely that these findings reflect a functional and adap-
tive reaction to remove particles by phagocytosis. We find
that the reported data are consistent with particle clearance
by phagocytic cells with no significant ROS production and
that they therefore should not be considered adverse or indi-
cative of a genotoxic effect. In a recent review, comet results
were attributed little weight because no clear link has been
demonstrated between DNA strand breaks and mutagenesis
or carcinogenesis (Møller and Jacobsen 2017).
Consistent with the hitherto generally accepted secondary
genotoxicity mechanism, oxidative DNA lesions (8-oxo-deoxy-
guanosine adducts) in carbon black exposed rats were only
found at inflammogenic exposure concentrations and were
mainly related to a marked neutrophil influx; similarly, persist-
ent lung inflammation was necessary to induce hprt muta-
tions in lung epithelial cells of carbon black exposed rats.
Importantly, the mutations could be prevented by treatment
with the antioxidant catalase, further supporting the role of
ROS, and thus secondary genotoxicity, in the generation of
mutations (Driscoll 1996; Driscoll et al. 1996, 1997; Elder et al.
2005; Ziemann et al. 2011; Rittinghausen et al. 2013).
Therefore, particle exposures that do not overwhelm host
defense mechanisms and hence do not elicit inflammatory
and proliferative responses would not be expected to pose
an increased risk of secondary genotoxicity. In the rat, which
is the most responsive species under particle overload condi-
tions, an inhalation NOAEL of 1.0mg/m3 respirable carbon
black has been established in sub-chronic studies, with signs
of mild inflammation found at the next higher tested dose
level of 7mg/m3 (LOAEL) (Driscoll 1996; Driscoll et al. 1996,
1997; Gallagher et al. 2003; Elder et al. 2005; Carter et al.
2006).
In summary, genotoxic effects are not expected to occur
under conditions that do not induce persistent and pro-
longed inflammation.
Evaluating the evidence for reproductive toxicity
To date, there are a number of instillation studies and one
short-term inhalation study that have evaluated selected end-
points related to reproduction and developmental toxicity;
usually at one time point and/or using a single dose level
only. One developmental study via the oral route was also
identified [(Ramesh 2012) as cited in SCCS (2015)]. Although
the oral route has limited relevance as a potential route of
exposure for carbon black in both occupational and con-
sumer scenarios, for the sake of completeness, it is worth not-
ing the conclusions of this developmental toxicity study. The
study authors concluded that oral administration of carbon
black to pregnant rats at 100, 300, or 1000mg/kg body
weight/day during the sensitive period of organogenesis was
well tolerated, and that there were no adverse maternal
changes or any effects on embryo-fetal development
(Ramesh 2012). However, inhalation represents the main
route of exposure in the occupational setting, and a complete
guideline developmental toxicity study using the inhalation
exposure route is not available. A number of review papers
on the reproductive and developmental toxicity of inhaled
nanomaterials, including carbon black, also conclude that the
available studies are limited and do not allow for definitive
conclusions (Ema et al. 2015; Hougaard et al. 2015). An over-
view of available studies with carbon black on reproductive
and developmental endpoints is shown in Table 3, and is dis-
cussed below.
Sexual maturation, fertility, and reproduction
In a study evaluating the effects of carbon black on the sex-
ual development and neurofunction of mice exposed in utero
to carbon black, Jackson et al. (2011) intratracheally instilled
pregnant mice on gestational days 7, 10, 15, and 18 to one
of three concentrations of carbon black (Printex 90; 2.75,
13.5, or 67 mg in 40 ml water). Final cumulative doses were 11,
54, or 268 mg/animal. Marked inflammation, sustained
throughout the lactation period (until weaning) was recorded
only in those dams exposed to a total dose of 268mg/animal
carbon black. Gestational and litter parameters were normal
for dams and offspring. Sexual development, characterized as
anogenital distance in weanlings and as the onset of puberty
was unchanged. The results on neurofunction are described
below under developmental effects.
In utero exposed mice did not exhibit adverse effects on
various reproduction parameters after intratracheal instillation
of a total dose of 267 mg/animal carbon black over the gesta-
tion period of 7–18 days (instillation on GD 7, 10, 15, 18, and
67 mg/instillation) (Kyjovska et al. 2013). Values for testicular
weight, relative testicular weight as well as sperm content per
gram testicular tissue and daily sperm production were similar
to controls. The male progeny of in utero treated males and
untreated females displayed slightly reduced daily sperm pro-
duction in comparison with matched controls. The single dose
regimen used in the study precludes any assessment of dos-
e–response relationships. Also, F2 males were analyzed at only
one time point as young adults (post-natal day 80). Although
the findings (a slight reduction in sperm production) were stat-
istically significant, only one time point and one dose was
evaluated, which is a weakness in the study.
In another study, male mice were intratracheally instilled
with carbon black (different groups received Printex 90
(14 nm primary particle size), Printex 25 (56 nm primary par-
ticle size), and Flammruss 101 (95 nm primary particle size) at
a dose of 100mg given 10 times at weekly intervals (resulting
in a total dose of 1000mg) (Yoshida et al. 2009). Observed
effects included increased testosterone with exposure to
Printex 90 and Printex 25, changes in seminiferous tubules
and decreased daily sperm production with all three carbon
blacks. The dose used was very high (totaling1000 mg),
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therefore it was not possible to determine the relevance of
these effects at more reasonable doses or if there is a dose–r-
esponse for this reported effect.
In a subsequent study, pregnant mice were intratracheally
instilled with carbon black at 200 mg/mouse on GD 7 and 14,
resulting in a total dose of 400 mg (Yoshida et al. 2010). In
this study, male offspring were evaluated at 5, 10, and
15weeks after birth. They showed histological changes in the
testes, as well as decreases in daily sperm production. There
were no changes in body weight, testicle weight, epididymis
weight, or serum testosterone levels in male offspring. Only
one high dose was used, therefore it was not possible to
determine if these effects are relevant at lower doses that
may be more representative of human exposures or to deter-
mine any possible dose-response relationship.
Developmental effects
An oral (gavage) prenatal development toxicity study in rats
was conducted with carbon black following OECD Guideline
No. 414 (Ramesh 2012). The carbon black used in this study
had a very low PAH content [total PAH <0.5 ppm and ben-
zo(a)pyrene <0.005 ppm] and is permitted for use in cosmet-
ics. In this study, rats were administered doses of 0, 100, 300,
or 1000mg/kg body weight/day carbon black by oral gavage
on days 5 through 19 of gestation. Maternal evaluations and
measurements included daily clinical signs and body weight/
food intake measured at designated intervals. No deaths
were observed. Dark colored feces were observed in all ani-
mals given carbon black which is related to the color of the
test substance. This finding is therefore considered to be
non-adverse. There were no changes in litter parameters, and
there were no fetuses with major malformations. Minor fetal
anomalies and normal variants observed were of the type
and incidences commonly observed in rats of this strain and
age and hence were considered to be incidental. The study
authors concluded that oral administration of carbon black to
pregnant rats at 100, 300, or 1000mg/kg body weight/day
during the sensitive period of organogenesis was well toler-
ated. There were no adverse maternal changes or any effects
on embryo-fetal development. Accordingly, under the condi-
tions of this study, NOAEL for maternal toxicity and the NOEL
for developmental toxicity were both set at 1000mg/kg body
weight/day.
Jackson et al. (2012a) conducted an inhalation and instilla-
tion study with carbon black to examine its effects on the
development of in utero exposed offspring. In the inhalation
part of the study, carbon black was administered to pregnant
mice at a single concentration of ca. 42mg/m3 for 1 h/day
from days 8 through 18 of gestation. DNA damage and lung
inflammation were examined 5 and 24 days after cessation of
exposure in dams. On post-natal days (PND) 2, 22–23, and 50,
livers of offspring animals were subjected to DNA analyzes.
Treatment resulted in the generation of an increase in poly-
morphonuclear neutrophil (PMN) associated inflammation in
the lungs of dams, which was detected 5 days after exposure
and sustained at the 24 day post-exposure observation time
point. The level of DNA strand breaks was increased in the
liver cells of dams at both sampling time points: 5 and
24 days after exposure and in liver of weanlings (PND 22–23)
and in adolescent (PND 50) offspring when compared to
matched controls. However, in BAL cells, DNA damage was
not evident. Neither the inhalation or instillation exposure
routes resulted in effects on gestational and lactation param-
eters assessed in dams, or developmental effects in the off-
spring (Jackson et al. 2012a). DNA strand breaks on its own
cannot be considered as reproductive toxicity as there is no
indication that this would result in heritable chromosomal
changes.
In the instillation part of the Jackson et al. study, carbon
black, suspended in water, was administered intratracheally
to three groups of time-mated pregnant mice on gestations
days 7, 10, 15, and 18. The final doses over the four instilla-
tion time points were 11, 54, and 268 mg carbon black/animal,
respectively. DNA damage and lung inflammation were exam-
ined in dams 3–4 and 26–27 days after cessation of exposure.
In the offspring, DNA analyzes were performed on post-natal
days (PND) 2, 24–25, and 47 to probe for DNA damage.
Intratracheal instillation did not result in DNA damage
(Jackson et al. 2012a).
In a separate publication, the toxicogenomic effects after
treatment were evaluated for dams, 26–27 days; and for neo-
nates, 4 days after cessation of exposure (Jackson et al.
2012b). There was no effect on gestational and lactation
parameters assessed in dams or developmental effects in the
offspring. Histological analyzes indicated retention of carbon
black particles in lungs of dams from both the medium and
the high dose groups. Nevertheless, persistent neutrophil-
marked inflammation, measured in BALF, was confined to the
high dose animals only. Results from histological analysis of
lung tissue correlated well with BAL findings and indicated a
thickening of the alveolar septa with simultaneous interstitial
infiltration of macrophages and neutrophils in the high dose
animals. However, despite the evidence of sustained inflam-
mation, collagen deposition, a hallmark feature of fibrosis,
was not evident. The exposure to carbon black also did not
affect the level of DNA strand breaks in BAL cells of dams or
in liver cells of dams and offspring. Toxicogenomic analysis
revealed altered expression of several inflammatory regulators
such as cytokines and chemokines in dams, both at the tran-
scriptional and tissue protein levels, which was significant
only in the high dose group (Jackson et al. 2012b).
Neurodevelopmental parameters in the offspring were
part of the intratracheal mouse study performed by Jackson
et al. (2011) and described above in more detail (Jackson
et al. 2011). Behavioral testing, performed only with animals
of the control and high dose groups (268 mg/mice), revealed
a different pattern of habituation in the female offspring
only. Contrary to the males, females moved differently in
open field tests during the first 2min compared with control;
total ambulation decreased significantly during the first
minute of observation and increased significantly in the
second minute of observation compared with that of con-
trols. The authors speculate that the aberrant movement
pattern is more likely a result of maternal inflammation than
a direct particle effect on offspring. No effects on gestation
and lactation were observed in this study (Jackson et al.
2011).
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Several studies have been conducted that evaluated differ-
ent endpoints in the offspring of in utero treated animals,
including effects on the brain, kidney, genotoxicity, and
immune system. Pregnant mice were intranasally instilled
with Printex 90 at 95 mg/kg/day on GD 5 and 9, and brains
were collected from male offspring at 6 and 12weeks after
birth (Onoda et al. 2014). The brains showed enlargement of
granules of perivascular macrophages and changes in astro-
cyte phenotypes. The authors state that these changes indi-
cate increased risk of dysfunction and disorder in the
offspring brain although a treated but intact satellite group
was not included in the study to further investigate and sup-
port or refute this claim. In the only primate study available
for developmental endpoints for carbon black, pregnant rhe-
sus macaque monkeys were injected intradermally with
carbon black suspended in 0.1% Tween 80 at a dose of
10mg/ml 4–6 times at intervals of 10–12 days. It is not clear
whether 1ml was injected each time; therefore, the total
dose injected is uncertain. Diesel exhaust particulates and
titanium dioxide were also used as test materials in different
animals. The brains collected from newborn infants showed
higher levels of hemoglobin compared to control animals.
The study showed that diesel exhaust particulates caused the
highest levels of hemoglobin. The authors state that the
altered hemoglobin was likely due to responses to oxidative
stress and/or hypoxia in the fetal brain. Maternal adverse
effects were not evaluated in the study, so that it is not pos-
sible to determine whether the effects on the fetus are a sec-
ondary non-specific consequence of overall maternal toxicity.
The authors also state that hemoglobin upregulation may be
a consequence of oxidative or inflammatory stress, or hyp-
oxia; therefore, at least initially, the increased hemoglobin is
a protective mechanism. The authors state that higher levels
of hemoglobin are reportedly neurotoxic; however, the level
of increase necessary to cause neurotoxicity is not stated
(Mitsunaga et al. 2016).
In a study evaluating the kidney as an endpoint, pregnant
mice were intratracheally instilled with Printex 90 at 50 mg/
mouse on GD 5 and 9, resulting in a total dose of 100 mg
(Umezawa et al. 2011). There was increased expression of col-
lagen type VIII in the kidney of 12-week-old offspring mice
but not in 3-week-old offspring mice. There was no difference
in levels of serum creatinine or blood urea nitrogen. The rele-
vance of this finding is not clear because no changes were
noted in kidney function.
In mice, oral doses of carbon black administered during
pregnancy did not increase the number of eye-spots in the
offspring (Reliene et al. 2005). Eye-spots are the results of
somatic reversions or deletions at the pink-eyed unstable
mutation site (pun site). Twenty days old offspring of
treated dams were sacrificed, eyes removed, and retinal
pigment epithelium (RPE) slides prepared for eye-spot
analysis.
Pregnant mice were intranasally instilled with Printex
90 (95mg/kg/day) on GD 9 and 15 (El-Sayed et al. 2015). The
thymus and spleen were collected from the offspring on post-
natal days 1, 3, and 5. Increases in thymocyte and lymphocyte
counts were seen in male offspring. Another study using a
similar exposure regimen showed that prenatal intranasal
instillations of carbon black on GD 5 and 9 induced immuno-
suppression in newborn mice, which was characterized by the
depletion of splenic cells in newborn mice (Shimizu et al.
2014). El-Sayed et al. (2015) has noted the apparent contrast
in the results obtained by Shimizu et al. (2014). It is therefore
difficult to ascertain the relevance of these findings.
Fedulov et al. (2008) investigated whether neonatal suscep-
tibility to asthma is elevated following in utero exposure to
particles such as diesel exhaust particles, carbon black or titan-
ium dioxide. They administered a single intranasal dose of
50 mg carbon black to pregnant mice (Balb/c) on day 14 of ges-
tation. After birth (post-natal day 4), offspring of treated dams
were sensitized by an intraperitoneal injection of ovalbumin
(OVA) and challenged on post-natal days 12–14 with aerosol-
ized 3% OVA. Post-challenge, mice were subjected to pulmon-
ary function and pathologic analysis. Airway responsiveness,
analyzed using whole body plethysmography, was a measure
for allergic response. The offspring showed increased suscepti-
bility to allergy. However, there is a scientific debate on
whether the applied plethysmography technique accurately
and reliably measures lung mechanics in small laboratory ani-
mals such as mice. Some authors have reported theoretical
and practical problems with the technique (Petak et al. 2001;
Albertine et al. 2002; Adler et al. 2004), whereas others have
reported good correlation between enhanced pause (Penh)
measurements and other assays of airway responsiveness
(Hamelmann et al. 1997; Finotto et al. 2001; Lee et al. 2008).
Evaluation of studies
Table 3 summarizes studies that evaluate reproductive and
developmental toxicity endpoints for carbon black. There is
one oral gavage study that was conducted using a standard
OECD protocol (OECD 414; prenatal developmental toxicity
study). The other studies were conducted using non-standard
or novel approaches, and typically evaluated very limited and
specific endpoints. Because each of these studies has limita-
tions, such as test material characterization, test material
administration using non-physiological routes (such as intra-
tracheal instillation), use of high or single doses etc., a
weight-of-evidence approach is used to assess the available
studies for the reproductive and developmental toxicity of
carbon black.
Test material preparation. Most of the reported studies
evaluating reproductive toxicity endpoints administered the
test material via intranasal or intratracheal instillation. Such
an administration method requires that the test material be
suspended in water or other solution. Some of the test meth-
ods involved aggressive means of suspending carbon black,
such as sonicating for up to 30min, filtering to exclude larger
aggregates/agglomerates, and use of dispersing agents such
as Tween 80 to achieve and maintain a homogenous distribu-
tion of test particles in solution. It has been noted, however,
that exposure to extraneous surfactants can disturb the
homeostasis of endogenous surfactants of the lungs.
Additionally, such dispersing agents can also generate
adverse effects themselves (Driscoll et al. 2000). These disper-
sion methods might have resulted in breaking down carbon
CRITICAL REVIEWS IN TOXICOLOGY 163
black agglomerates into aggregates, such that the size of the
carbon black may be substantially different from the agglom-
erated form that is typically encountered in the workplace
environment.
Dosing. Most of the reproductive toxicity studies with car-
bon black use single or multiple instillations, which may be
useful preliminary screens to explore a potential hazard,
develop hypotheses or, compare differences between test
materials. However, ECETOC (2013) noted that “A major con-
cern regarding the use of intratracheal instillation is that the
introduction of a large bolus dose of the test substance into
the lung in a short period of time will overwhelm the normal
lung response and defense systems to the extent that it may
produce responses that are pathophysiological artifacts that
would not be seen if the same dose was delivered over a lon-
ger period of time via an inhalation exposure. This can thus
produce serious problems for the interpretation of both haz-
ard identification and risk assessment.” If the instillation
method with high doses produces no adverse effects then it
is unlikely that adverse effects would be observed at lower
doses given over a longer period of time. However, if the
instillation method shows adverse effects, it would be reason-
able to then conduct inhalation studies to see if these effects
are still observed with physiological exposure routes and
doses that are more relevant for human exposures.
Many of the studies used single doses and/or very high
doses of carbon black. The one inhalation study available for
evaluating reproductive and developmental toxicity endpoints
used an aerosol concentration of 42mg/m3 administered 1 h/
day to pregnant mice during gestation days 8–18 (Jackson
et al. 2012a). Jackson et al. justify this high aerosol concentra-
tion by stating that the dose of 1 h exposure to 42mg Printex
90/m3 corresponds to only one-and-a-half day exposure that
Danish workers might experience at the time-weighted aver-
age occupational exposure limit (3.5mg/m3 as an 8-h time-
weighted average for carbon black). However, this extrapola-
tion does not account for the large differences between
humans and mice in factors such as body weight, breathing
rates, lung surface area etc. For example, Erdely et al. (2013)
developed mouse inhalation doses for a test material by
extrapolating from human to mouse alveolar depositions,
which accounted for the difference between the human alveo-
lar surface area of 102 m2 compared to the mouse alveolar
surface area of 0.05 m2. This extrapolation exercise shows that
there are orders of magnitude differences in physiological
parameters between humans and mice. It is also noted that
mice were dosed with 42mg/m3 carbon black for 1 h/day over
11 days (gestation days 8–18), which is a very high exposure
that is likely to overwhelm normal lung defense responses.
Many of the instillation studies also use a single dose,
rather than a range of doses thus precluding evaluation of a
dose–response effect. Some of the instillation doses used are
also quite high; for example, Jackson et al. (2012a, 2012b)
use a high dose of 268 mg/mouse, and Yoshida et al. (2009)
instilled 100 mg/mouse at 10 weekly intervals resulting in a
total dose of 1000mg/mouse. In contrast, researchers at the
US National Institute of Occupational Safety and Health
(NIOSH) typically use doses under 100 mg/mouse for pharyn-
geal aspiration studies of nanoparticles as these doses usually
fall below lung overload in the mouse model. At a carbon
black (Printex 90) dose of 40 mg/mouse, Roberts et al. (2016)
found increased but transient inflammation in the lung. While
the use of a high dose indicates that it may be possible to
evoke certain adverse effects, the interpretation of such find-
ings for hazard identification and human risk assessment is
not clear because of the generation of potential artifactual
effects.
Screening level studies looking at specific endpoints. As noted
in a review of reproductive and developmental toxicity of car-
bon-based nanomaterials (Ema et al. 2015), none of the rodent
studies evaluating airway exposure of carbon black used a
standard guideline testing approach. Many of the studies
looked at very specific post-natal endpoints, such as lympho-
cyte count in thymus and spleen, perivascular macrophages in
brain, collagen in the kidney, etc. It is not always clear what
are the overall effects on the offspring of changes in these
specific endpoints. Many of the studies also evaluated post-
natal effects at only one time point so that it is not clear if
there was recovery from some or all of the observed changes.
Weight-of-evidence for reproductive toxicity of carbon
black
It is important to consider the weight-of-evidence from all
the available studies to determine whether carbon black is
likely to act as a reproductive toxicant. Various regulatory
agencies recommend the use of weight-of-evidence in data
assessment. For example, the European Chemicals Agency
(ECHA 2015) states the following regarding reproductive tox-
icity: “the weight given to the available evidence will be influ-
enced by factors such as the quality of the studies,
consistency of results, nature and severity of effects, the pres-
ence of maternal toxicity in experimental animal studies, level
of statistical significance for inter-group differences, number
of endpoints affected, relevance of route of administration to
humans, and freedom from bias. Both positive and negative
results are assembled together into a weight of evidence
determination.” As discussed above, many of the short-term
studies evaluating reproductive toxicity of carbon black have
limitations, such as test material characterization, test material
administration using non-physiological routes (such as intra-
tracheal instillation), use of high doses, evaluation of very lim-
ited and specific endpoints, and lack of recovery period in
the studies. The one study that was conducted using a stand-
ard OECD protocol for developmental effects is an oral study
that reported no adverse maternal changes and no effects on
embryo-fetal development at the highest dose tested of
1000mg/kg body weight/day. Based on the chemical charac-
teristics of carbon black, toxicokinetic behavior, relevant
exposure levels, and understanding of mechanism of toxicity,
the overall weight of evidence indicates that carbon black
should not be considered a reproductive toxicant.
Summary and conclusions
Carbon black has been extensively tested for its genotoxic
activity both in vitro and in vivo. The totality of available data
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is consistent with the interpretation that carbon black does
not directly interact with DNA. Increases in hprt mutation
frequencies were only noted at concentrations that were
clearly associated with marked pulmonary inflammation
(Driscoll et al. 1996, 1997). Further evidence supporting
that these mutations are due to a secondary mechanism
and not due to a direct interaction of carbon black with
DNA can be obtained by the negative results in DNA
adduct studies. These studies have demonstrated the inabil-
ity of carbon black to produce DNA adducts in the lungs
of rats and in human lung epithelial cells (Wolff et al.
1990; Gallagher et al. 1994; Borm et al. 2005; Danielsen
et al. 2010). Clearly, genetic damage might occur by ROS
generated as a consequence of impaired particle clearance,
i.e. under lung and macrophage overload conditions lead-
ing to pulmonary inflammation. In the rat, the most sensi-
tive species with regard to lung overload, a threshold
below which no genetic damage is expected to occur has
been derived from subchronic inhalation studies at 1mg/
m3. This value was the NOAEL for any inflammatory effects
including any increases in pro- or anti-inflammatory markers
in a well-conducted 90 day inhalation study (Driscoll et al.
1996; Elder et al. 2005). Biological responses described after
exposure to carbon black in vitro investigations tended to
be non-specific effects such as cytotoxicity and DNA strand
breaks due to often unrealistic and high exposure levels; in
only a few instances, were assay interferences controlled or
even considered. DNA strand breaks observed at sub-toxic
doses in macrophage cell lines and in vivo in BAL and lung
cells are considered to be due to particle clearance without
significant ROS production, and therefore should not be
considered as indicative of genotoxicity or as an adverse
toxicological effect.
For the reproductive toxicity endpoint, no adverse mater-
nal changes or any effects on embryo-fetal development
were seen at the highest dose tested of 1000mg/kg body
weight/day in an oral developmental toxicity study. However,
an oral study has limited relevance for interpretation into
human situations where inhalation is the most likely exposure
route. There are a number of short-term instillation studies
and one inhalation study available for carbon black that
evaluate endpoints related to reproductive toxicity in mice. In
the inhalation study, which was performed only at a single,
very high dose level (42mg/m3) during the whole sensitive
period of gestation, the gestational and post-gestational
parameters were not affected, and there were no develop-
mental effects observed in the offspring.
Various other short-term intratracheal instillation studies
looked at very specific post-natal endpoints; usually at one
single time point and with high dose instillations. The rele-
vance of the reported findings (altered habituation pattern,
decreased sperm production, intracerebral macrophage accu-
mulation, changes in immune parameters) to reproduction
and the overall development of the offspring cannot be fully
interpreted due to the lack of reported historical control data
for these endpoints and inconsistent results. It is also possible
that the effects observed in the instillation studies may be
the result of non-specific inflammatory effects caused by high
exposure doses.
Toxicokinetic studies on carbon black and similar carbon-
aceous materials indicate that industrially produced carbon
black is unlikely to be absorbed or distributed in the body.
Therefore, carbon black is unlikely to reach reproductive
organs and tissues and have a direct effect on reproductive
functions or the developing organism.
Thus, based on an overall weight-of-evidence evaluation
of the available published studies, industrially produced car-
bon black is neither considered to be a primary genotoxicant
nor a reproductive or developmental toxicant.
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